Lindbrook Capital LLC Sells 7,360 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Lindbrook Capital LLC trimmed its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 32.6% during the fourth quarter, Holdings Channel reports. The fund owned 15,246 shares of the exchange traded fund’s stock after selling 7,360 shares during the quarter. Lindbrook Capital LLC’s holdings in SPDR S&P Biotech ETF were worth $1,373,000 as of its most recent filing with the SEC.

A number of other institutional investors have also made changes to their positions in the stock. Healthcare of Ontario Pension Plan Trust Fund raised its stake in shares of SPDR S&P Biotech ETF by 198.6% in the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock valued at $911,825,000 after acquiring an additional 6,138,000 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd bought a new position in shares of SPDR S&P Biotech ETF in the 3rd quarter valued at approximately $141,284,000. Proficio Capital Partners LLC raised its stake in shares of SPDR S&P Biotech ETF by 16,156.1% in the 4th quarter. Proficio Capital Partners LLC now owns 917,329 shares of the exchange traded fund’s stock valued at $82,615,000 after acquiring an additional 911,686 shares in the last quarter. Mirae Asset Securities USA Inc. raised its stake in shares of SPDR S&P Biotech ETF by 50.0% in the 3rd quarter. Mirae Asset Securities USA Inc. now owns 900,000 shares of the exchange traded fund’s stock valued at $88,920,000 after acquiring an additional 300,000 shares in the last quarter. Finally, Raymond James Financial Inc. bought a new position in shares of SPDR S&P Biotech ETF in the 4th quarter valued at approximately $55,529,000.

SPDR S&P Biotech ETF Stock Performance

Shares of XBI stock opened at $87.82 on Thursday. The stock’s 50 day simple moving average is $90.68 and its 200 day simple moving average is $95.52. SPDR S&P Biotech ETF has a twelve month low of $81.14 and a twelve month high of $105.47. The company has a market capitalization of $5.79 billion, a price-to-earnings ratio of 11.47 and a beta of 0.93.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.